report strong result mark solid trend across divis
superb free cash flow raised/narrow guidanc addit compani
provid increment transpar around rebat think
allay view misplac concern around topic final
aet deal continu progress remain bullish sever aspect
combin expect continu roll-out addit value-ad
servic minuteclin video visit remain bullish reiter
buy price target ep
provid addit detail around topic increas recent discuss
view misplac concern rebat compani expect
retain rebat adjust ep roughli
rebat pass custom allow
drive cost lower addit provid point sale rebat
commerci member help lower out-of-pocket cost compani
underwrit contract level profit client fund
option final importantli compani highlight lack correl
rebat higher drug price drug minim competit
less incent provid rebat better price power
progress aetna aet nr acquisit continu
meaning number state approv expect post doj
approv deal expect close late compani
make on-going headway drive smooth transit achiev
synergi goal second full year strong season team place
lead combin compani continu like deal tie broaden
servic offer improv patient connect integr pharmacy/
medic patient manag addit expect addit patient offer
would highlight signific set tool combin compani
dispos drive qualiti outcom reduc cost
silverscript trend pbm segment remain strong adjust claim
gross margin flat oper incom ahead expect
sell season seen lower rfp activ net new win stand
tr target
total debt includ oper leas
compani complet renew roughli in-lin prior year
time see slightli higher retent rate standard control formulari continu drive
drug spend bend cost curv cumul save client sinc
launch roughli compani member impact plan remov
product add back silverscript continu hum along live
manag expect on-going robust trend encourag strong preliminari benchmark
result
compani grew retail revenu pharmaci ss sale total ss sale
front store ss sale essenti flat adjust holiday continu
gain retail pharmaci market share roughli fuel sever key driver store
brand make front store sale minuteclin revenu compani
boast clinic state minuteclin also offer video visit
patient leverag teledoc buy cover sandi draper technolog
continu view minuteclin differenti provid attract patient connect
think could area increas leverag time
ocr impair charg record goodwil impair charg tie
rise interest rate reduc peer multipl financi result expect bad
perform compani ad new leadership launch initi improv retent
grow penetr rate implement cost improv program target
save next year inher demograph tailwind continu see attract
valu omnicar busi manag look improv oper better posit
omnicar within market
effici continu pay compani streamlin initi continu produc
notic result across enterpris manag reiter expect gross
benefit process improv remain underway includ launch enhanc
autom prescript process reduc data entry/prescript edit time
applaud streamlin effort expect improv drive increment cost save
patient satisfact time
continu impress cash flow oper free cash flow come
well ahead estim forma ttm adjust debt-to-ebitda
expect manag goal move normal within year
post close view quit doabl give expect characterist combin
compani full year revenu adjust oper profit guidanc narrow expect growth
rang mid-point
ep guidanc rais rang narrow
increas adjust ep estim tie
result updat guidanc high convict solid underli trend
page
revenu
rev
rev
rev
page
health corpor base woonsocket ri oper retail store
walk-in medic clinic lead pbm million plan member state
district columbia puerto rico brazil acquisit omnicar pharmaci
store expand geograph presenc provid new distribut channel nurs pharmaci
enhanc differenti compani integr model
bullish tie solid compani specif overal industri trend gener util
demograph specialti growth addit view integr busi model well
posit provid multipl patient touch point think grow import given
environ increasingli driven consum choic focus total patient care final
signific scale across busi line strong balanc sheet robust cash flow gener
provid attract on-going capit deploy opportun
valuat risk
price target base stock trade ep slight premium
current multipl believ warrant given compani differenti busi model
strong new busi trend consist earn strong free cash flow pend aetna
acquisit downsid risk pt includ lower expect pbm retent rate increas
regulatori scrutini inabl integr acquisit effect loss retail market share tie
increas competit
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
